SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 90 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.12 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $398,000 | +33.6% | 19,530 | 0.0% | 0.36% | +41.7% |
| Q1 2016 | $298,000 | +12.0% | 19,530 | -1.3% | 0.25% | +30.6% |
| Q4 2015 | $266,000 | -4.3% | 19,780 | 0.0% | 0.19% | -2.5% |
| Q3 2015 | $278,000 | -79.5% | 19,780 | -75.3% | 0.20% | -76.9% |
| Q2 2015 | $1,357,000 | +40.3% | 79,922 | -0.1% | 0.86% | +53.1% |
| Q1 2015 | $967,000 | +45.4% | 80,022 | -0.1% | 0.56% | +34.5% |
| Q4 2014 | $665,000 | +143.6% | 80,135 | +154.9% | 0.42% | +176.2% |
| Q3 2014 | $273,000 | -9.0% | 31,435 | +14.6% | 0.15% | -1.9% |
| Q2 2014 | $300,000 | +22.4% | 27,435 | 0.0% | 0.15% | +26.2% |
| Q1 2014 | $245,000 | – | 27,435 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |